BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20237793)

  • 1. A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies.
    Berndt A; Köllner R; Richter P; Franz M; Voigt A; Berndt A; Borsi L; Giavazzi R; Neri D; Kosmehl H
    Histochem Cell Biol; 2010 Apr; 133(4):467-75. PubMed ID: 20237793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential vascular expression and regulation of oncofetal tenascin-C and fibronectin variants in renal cell carcinoma (RCC): implications for an individualized angiogenesis-related targeted drug delivery.
    Galler K; Junker K; Franz M; Hentschel J; Richter P; Gajda M; Göhlert A; von Eggeling F; Heller R; Giavazzi R; Neri D; Kosmehl H; Wunderlich H; Berndt A
    Histochem Cell Biol; 2012 Feb; 137(2):195-204. PubMed ID: 22075565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.
    Berndt A; Richter P; Kosmehl H; Franz M
    Cell Adh Migr; 2015; 9(1-2):105-11. PubMed ID: 25793577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.
    Franz M; Brehm BR; Richter P; Gruen K; Neri D; Kosmehl H; Hekmat K; Renner A; Gummert J; Figulla HR; Berndt A
    J Mol Histol; 2010 Feb; 41(1):39-50. PubMed ID: 20232238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative co-localization analysis of large unspliced tenascin-C(L) and laminin-5/gamma2-chain in basement membranes of oral squamous cell carcinoma by confocal laser scanning microscopy.
    Franz M; Hansen T; Borsi L; Geier C; Hyckel P; Schleier P; Richter P; Altendorf-Hofmann A; Kosmehl H; Berndt A
    J Oral Pathol Med; 2007 Jan; 36(1):6-11. PubMed ID: 17181735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
    Ringelmann B; Röder C; Hallmann R; Maley M; Davies M; Grounds M; Sorokin L
    Exp Cell Res; 1999 Jan; 246(1):165-82. PubMed ID: 9882526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder.
    Berndt A; Anger K; Richter P; Borsi L; Brack S; Silacci M; Franz M; Wunderlich H; Gajda M; Zardi L; Neri D; Kosmehl H
    J Cancer Res Clin Oncol; 2006 Aug; 132(8):537-46. PubMed ID: 16788848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleft palate formation in fetal Br mice with midfacial retrusion: tenascin, fibronectin, laminin, and type IV collagen immunolocalization.
    Singh GD; Johnston J; Ma W; Lozanoff S
    Cleft Palate Craniofac J; 1998 Jan; 35(1):65-76. PubMed ID: 9482226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin and fibronectin isoforms in human renal cell carcinomas, renal cell carcinoma cell lines and xenografts in nude mice.
    Lohi J; Tani T; Laitinen L; Kangas L; Lehto VP; Virtanen I
    Int J Cancer; 1995 Nov; 63(3):442-9. PubMed ID: 7591246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Salmas M; Malamou-Mitsi V
    BJU Int; 2005 Mar; 95(4):655-9. PubMed ID: 15705098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of oncofetal fibronectin and tenascin-C expression in right atrial auricular and left ventricular human cardiac tissue from patients with coronary artery disease and aortic valve stenosis.
    Baldinger A; Brehm BR; Richter P; Bossert T; Gruen K; Hekmat K; Kosmehl H; Neri D; Figulla HR; Berndt A; Franz M
    Histochem Cell Biol; 2011 May; 135(5):427-41. PubMed ID: 21479812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects.
    Kosmehl H; Berndt A; Katenkamp D
    Virchows Arch; 1996 Dec; 429(6):311-22. PubMed ID: 8982375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms.
    Hauptmann S; Zardi L; Siri A; Carnemolla B; Borsi L; Castellucci M; Klosterhalfen B; Hartung P; Weis J; Stöcker G
    Lab Invest; 1995 Aug; 73(2):172-82. PubMed ID: 7543628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea.
    Tuori A; Virtanen I; Aine E; Uusitalo H
    Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):222-9. PubMed ID: 9143890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma.
    Kosmehl H; Berndt A; Strassburger S; Borsi L; Rousselle P; Mandel U; Hyckel P; Zardi L; Katenkamp D
    Br J Cancer; 1999 Nov; 81(6):1071-9. PubMed ID: 10576667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
    Ioachim E; Charchanti A; Briasoulis E; Karavasilis V; Tsanou H; Arvanitis DL; Agnantis NJ; Pavlidis N
    Eur J Cancer; 2002 Dec; 38(18):2362-70. PubMed ID: 12460779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma.
    Katenkamp K; Berndt A; Hindermann W; Wunderlich H; Haas KM; Borsi L; Zardi L; Kosmehl H
    J Pathol; 2004 Jul; 203(3):771-9. PubMed ID: 15221936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.
    Franz M; Matusiak-Brückner M; Richter P; Grün K; Ziffels B; Neri D; Maschek H; Schulz U; Pfeil A; Jung C; Figulla HR; Gummert J; Berndt A; Renner A
    J Mol Histol; 2014 Oct; 45(5):519-32. PubMed ID: 24792713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal laminin chain distribution in normal, hyperplastic and malignant oral mucosa: relation to myofibroblast occurrence and vessel formation.
    Franz M; Wolheim A; Richter P; Umbreit C; Dahse R; Driemel O; Hyckel P; Virtanen I; Kosmehl H; Berndt A
    J Oral Pathol Med; 2010 Apr; 39(4):290-8. PubMed ID: 19889153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast.
    Yoshida T; Matsumoto E; Hanamura N; Kalembeyi I; Katsuta K; Ishihara A; Sakakura T
    J Pathol; 1997 Aug; 182(4):421-8. PubMed ID: 9306963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.